Procter & Gamble reported fiscal first-quarter 2027 net sales of $23.3 billion, up 4%, with diluted EPS of $1.97, up 1%. It raised its all-in fiscal 2027 sales growth guidance to 2% to 4% to reflect the Thorne acquisition, while keeping its organic sales, EPS and cash return guidance, but it now expects a commodity cost headwind of about $1.4 billion after tax.
Net sales of $23.3 billion, up 4%; organic sales also up 4%, with volume up 2%
Diluted EPS of $1.97, up 1%; core EPS of $2.00, up 1%
All-in fiscal 2027 sales growth guidance raised to 2% to 4%, reflecting Thorne acquisition as of October 1, 2026; organic sales guidance of 1% to 3% maintained
Fiscal 2027 diluted EPS growth guidance of 1% to 5% maintained, with a commodity cost headwind of about $1.4 billion after tax
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Procter & Gamble's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2026
$87.03B
+3.3%
$6.62
+1.7%
18.4%
FY2025
$84.28B
+0.3%
$6.51
+8.1%
19.0%
FY2024
$84.04B
+2.5%
$6.02
+2.0%
17.7%
FY2023
$82.01B
+2.3%
$5.90
+1.5%
17.9%
FY2022
$80.19B
+5.3%
$5.81
+5.6%
18.4%
Frequently asked questions
When is Procter & Gamble's next earnings date?
Procter & Gamble has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Procter & Gamble earn last quarter?
For the quarter ended Sep 2026, Procter & Gamble reported diluted EPS of $1.97 (+1.0% year over year) on revenue of $23.28B (+4.0%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.